ZoeDianaDraelosMD

Dermatology • High Point, NC

Dermatologic Surgery, Dermatopathology, Pediatric Dermatology

Consulting Professor in the Department of Dermatology, Duke University School of Medicine

Join to view full profile

Are you Dr. Draelos?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 44 invites waiting!
Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

Office
2444 N Main St
High Point, NC 27262
Phone+1 336-841-2040

Fax+1 336-841-2044

Summary

Dr. Zoe Draelos, MD is a board certified dermatologist in High Point, North Carolina. She is currently licensed to practice medicine in North Carolina and Arizona. She is affiliated with High Point Medical Center and Novant Health Thomasville Medical Center.

Education & Training

University of Arizona College of Medicine-TucsonResidency, Dermatology, 1984 - 1987
University of Arizona College of Medicine-TucsonInternship, Internal Medicine, 1983 - 1984
University of Arizona College of MedicineClass of 1983

Certifications & Licensure

AZ State Medical License 1987 - Present
NC State Medical License 1987 - 2025
American Board of Dermatology Dermatology

Awards, Honors, & Recognition

Whos Who in Medicine and Healthcare Marquis Whos Who
Fellow (FAAD) American Academy of Dermatology

Clinical Trials

Effect of Revival Soy on Weight Loss and Skin, Hair, and Nails in Premenopausal Women Start of enrollment: 2006 Jul 01
Completed
Phase 4
Study to Determine if Tetrix Cream is Removed From the Hands by Gentle Washing With Soap and Water Start of enrollment: 2007 Nov 01
Completed
Not Applicable
Epiduo Pediatric Acne Study Start of enrollment: 2010 Jun 01
Completed
Phase 4
Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea Start of enrollment: 2010 Aug 01
Completed
Phase 2
Efficacy and Tolerability Study of Device, RD047-26 for the Treatment of Mild to Moderate Atopic Dermatitis in Adults Start of enrollment: 2010 Oct 01
Completed
Phase 2
Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea Start of enrollment: 2011 May 01
Completed
Phase 3
VPD-737 for Treatment of Chronic Pruritus Start of enrollment: 2013 Oct 15
Completed
Phase 2
DFD01 Spray vs Comp01 Lotion HPA Axis Suppression Study in Patients With Moderate to Severe Plaque Psoriasis Start of enrollment: 2014 Jan 01
Completed
Phase 2
ACT01 in Combination With Comp01-04 in Patients With Actinic Keratosis Start of enrollment: 2014 Apr 01
Completed
Phase 2
A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris Start of enrollment: 2015 Apr 01
Completed
Phase 2
A Study of the Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate to Severe Plaque Psoriasis Start of enrollment: 2015 Dec 01
Completed
Phase 3
The Suitability of Two Skin Care Regimens in Moderate to Severe Facial Rosacea Start of enrollment: 2018 Jan 01
Completed
Not Applicable
Efficacy of a Nutritional Supplement on Skin Health in Generally Healthy Adults Start of enrollment: 2020 Jan 14
Completed
Not Applicable
Join now to see all

Publications & Presentations

PubMed

189 citations
Skin cancer and photoprotection in people of color: A review and recommendations for physicians and the public
Oma N. Agbai, Kesha J. Buster, Miguel Sanchez, Claudia Hernandez, Roopal V. Kundu
Journal of the American Academy of Dermatology. 2014-04-01
6 citations
A Randomized, Controlled Trial of Trifarotene Plus Doxycycline for Severe Acne Vulgaris.
James Q Del Rosso, Sandra Marchese Johnson, Todd Schlesinger, Lawrence Green, Nestor Sanchez
The Journal of Clinical and Aesthetic Dermatology. 2022-07-01
697 citations
Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis
Wolfgang Hueber, Dhavalkumar D. Patel, Thaddeus P. Dryja, Andrew M Wright, Irina Koroleva
Science Translational Medicine. 2010-10-06

Authored Content

Trial of Roflumilast Cream for Chronic Plaque PsoriasisJuly 2020
The Role of ’Biotics in SkincareApril 2020

Press Mentions

Studies Show Sun Pharma's WINLEVI® (Clascoterone) Cream 1% Reduces Sebum Levels and Is Suitable for Combination with Other Commonly Used Topical Acne MedicationsOctober 25th, 2024
Assessing Itch in Plaque Psoriasis: The Latest Tools & QuestionnairesOctober 3rd, 2024
Arcutis Highlights Advanced Pipeline & Unique Immuno-Dermatology Drug Development Capabilities at Virtual Investor Day on December 9, 2020December 9th, 2020
Join now to see all

Professional Memberships

American Academy of Dermatology - AAD
Fellow